Common use of Filing of Form 8-K and Registration Statement Clause in Contracts

Filing of Form 8-K and Registration Statement. The Company agrees that it shall, within the time required under the Exchange Act file a Report on Form 8-K disclosing this Agreement and the transaction contemplated hereby. The Company shall also file within twenty (20) Business Days from the date hereof a new registration statement covering only the sale of the Purchase Shares (it being understood that the Company shall determine the number of Purchase Shares to be registered initially and subsequently) and the Additional Commitment Shares, in accordance with the terms of the Registration Rights Agreement between the Company and the Investor, dated as of the date hereof (“Registration Rights Agreement”). Any securities issuable under this Agreement that have not been registered under the Securities Act shall bear the following restrictive legend (the “Restrictive Legend”):

Appears in 1 contract

Sources: Purchase Agreement (Cytosorbents Corp)

Filing of Form 8-K and Registration Statement. The Company agrees that it shall, within the time required under the Exchange Act file a Report on Form 8-K disclosing this Agreement and the transaction contemplated hereby. The Company shall also file within twenty sixty (2060) Business Days from the date hereof a new registration statement covering only the sale of the Purchase Shares (it being understood that the Company shall determine the number of Purchase Shares to be registered initially and subsequently) and the Additional Commitment Shares, in accordance with the terms of the Registration Rights Agreement between the Company and the Investor, dated as of the date hereof (“Registration Rights Agreement”). Any securities issuable under this Agreement that have not been registered under the Securities Act shall bear the following restrictive legend (the “Restrictive Legend”):

Appears in 1 contract

Sources: Purchase Agreement (Cytosorbents Corp)

Filing of Form 8-K and Registration Statement. The Company agrees that it shall, within the time required under the Exchange Act file a Report on Form 8-K disclosing this Agreement and the transaction contemplated hereby. The Company shall also file within twenty ten (2010) Business Days from the date hereof a new registration statement covering only the sale of the Purchase Shares (it being understood that other than the Company shall determine the number of Initial Purchase Shares to be registered initially and subsequentlyShares) and the Additional Commitment Shares, in accordance with the terms of the Registration Rights Agreement between the Company and the Investor, dated as of the date hereof (“Registration Rights Agreement”). Any securities issuable under this Agreement that have not been registered under the Securities Act shall bear the following restrictive legend (the “Restrictive Legend”):

Appears in 1 contract

Sources: Purchase Agreement (Puramed Bioscience Inc.)